Narcosynthesis
CPT code 90865 covers narcosynthesis, a psychiatric interview technique where medication is administered intravenously to help patients recall repressed memories or reveal information they cannot access in a normal state of consciousness.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Clearly document the medical necessity and failure of conventional psychiatric evaluation methods before narcosynthesis, as payers often consider this an investigational or last-resort procedure
Impact: Proper medical necessity documentation reduces denial rate by 60-70% and is critical for the $155.59 non-facility or $117.09 facility payment
Bill in non-facility setting when performed in physician office with appropriate monitoring equipment to capture the additional $38.50 in practice expense reimbursement
Impact: Non-facility rate ($155.59) is 33% higher than facility rate ($117.09), adding $38.50 per procedure
Separately bill for the pharmaceutical agents used (J-codes for sodium amobarbital, benzodiazepines, etc.) as 90865 covers only the professional service component
Impact: Drug costs typically add $50-200 to total reimbursement depending on agent and dosage; failure to bill separately loses this revenue
Do not bill 90865 on the same day as standard psychiatric diagnostic evaluation (90791, 90792) without modifier 59, as payers will bundle services
Impact: Prevents automatic denial and loss of $117-156; modifier 59 must be supported by distinct documentation
Include continuous vital sign monitoring records, timing of medication administration, patient response documentation, and psychiatric findings in the medical record to support the 2.84 work RVUs
Impact: Comprehensive documentation supports full payment and reduces audit recoupment risk; audits of incomplete records result in 100% payment denial
Verify prior authorization requirements before scheduling, as many commercial payers classify narcosynthesis as experimental or requiring pre-certification
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.